BR9814904A - Polinucleotìdeo isolado que codifica um polipeptìdeo, polipeptìdeo isolado, e, anticorpo. - Google Patents
Polinucleotìdeo isolado que codifica um polipeptìdeo, polipeptìdeo isolado, e, anticorpo.Info
- Publication number
- BR9814904A BR9814904A BR9814904-0A BR9814904A BR9814904A BR 9814904 A BR9814904 A BR 9814904A BR 9814904 A BR9814904 A BR 9814904A BR 9814904 A BR9814904 A BR 9814904A
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptide
- isolated
- antibody
- polynucleotide encoding
- antibodies
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 5
- 102000040430 polynucleotide Human genes 0.000 title abstract 2
- 108091033319 polynucleotide Proteins 0.000 title abstract 2
- 239000002157 polynucleotide Substances 0.000 title abstract 2
- 101100072406 Mus musculus Il20 gene Proteins 0.000 abstract 2
- 230000035755 proliferation Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Environmental Sciences (AREA)
- Dermatology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biodiversity & Conservation Biology (AREA)
- Plant Pathology (AREA)
- Animal Husbandry (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Pulmonology (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97915697A | 1997-11-26 | 1997-11-26 | |
PCT/US1998/025228 WO1999027103A1 (en) | 1997-11-26 | 1998-11-25 | Mammalian cytokine-like polypeptide-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9814904A true BR9814904A (pt) | 2000-10-03 |
Family
ID=25526742
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9814904-0A BR9814904A (pt) | 1997-11-26 | 1998-11-25 | Polinucleotìdeo isolado que codifica um polipeptìdeo, polipeptìdeo isolado, e, anticorpo. |
Country Status (20)
Country | Link |
---|---|
EP (3) | EP1032671B1 (pt) |
JP (2) | JP5191619B2 (pt) |
KR (1) | KR100574387B1 (pt) |
CN (2) | CN1247780C (pt) |
AT (1) | ATE269902T1 (pt) |
AU (1) | AU739420B2 (pt) |
BR (1) | BR9814904A (pt) |
CA (1) | CA2312000C (pt) |
CZ (1) | CZ300849B6 (pt) |
DE (1) | DE69824755T2 (pt) |
DK (1) | DK1032671T3 (pt) |
EA (2) | EA010741B1 (pt) |
ES (1) | ES2218872T3 (pt) |
HU (1) | HU227703B1 (pt) |
IL (2) | IL136076A0 (pt) |
NO (2) | NO326561B1 (pt) |
NZ (1) | NZ504751A (pt) |
PL (2) | PL195304B1 (pt) |
UA (2) | UA86350C2 (pt) |
WO (1) | WO1999027103A1 (pt) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5945511A (en) * | 1997-02-20 | 1999-08-31 | Zymogenetics, Inc. | Class II cytokine receptor |
EP1246846B1 (en) | 1999-12-23 | 2008-09-10 | ZymoGenetics, Inc. | Soluble interleukin-20 receptor |
DK1616575T3 (da) * | 1999-12-23 | 2012-09-10 | Zymogenetics Inc | Fremgangsmåde til behandling af inflammation |
US6610286B2 (en) | 1999-12-23 | 2003-08-26 | Zymogenetics, Inc. | Method for treating inflammation using soluble receptors to interleukin-20 |
CA2418950A1 (en) | 2000-08-08 | 2002-02-14 | Zymogenetics, Inc. | Soluble zcytor 11 cytokine receptors |
ES2267814T3 (es) | 2000-09-15 | 2007-03-16 | Zymogenetics, Inc. | Metodo para tratar la inflamacion. |
CA2429044A1 (en) * | 2000-10-20 | 2002-05-02 | Zymogenetics, Inc. | Secreted alpha-helical cytokine-like protein zlmda24 |
WO2002058724A2 (en) * | 2001-01-26 | 2002-08-01 | Eli Lilly And Company | Use of lp82 to treat body weight disorders |
EP1383531A2 (en) | 2001-02-28 | 2004-01-28 | Eli Lilly And Company | Use of lp82 to treat hematopoietic disorders |
EP1439850A4 (en) * | 2001-10-22 | 2006-05-03 | Lilly Co Eli | SOLUBLE PROTEINS THAT RESIST CYTOKIN SIGNAL TRANSFER PATHS |
JP4532902B2 (ja) | 2001-12-17 | 2010-08-25 | ザイモジェネティクス,インコーポレイティド | 子宮頸部癌の治療方法 |
EA009124B1 (ru) | 2003-03-24 | 2007-10-26 | Займоджинетикс, Инк. | Антитела против il-20 и связывающие партнеры, а также способы их применения при воспалении |
JP2007501813A (ja) * | 2003-08-08 | 2007-02-01 | ノボ ノルディスク アクティーゼルスカブ | 新生血管形成と関連した症状を治療および診断するためのインターロイキン−20 |
WO2005052000A2 (en) * | 2003-11-21 | 2005-06-09 | Zymogenetics, Inc. | Anti-il-20 antibodies and binding partners and methods of using in inflammation |
DE602004032379D1 (de) | 2003-12-19 | 2011-06-01 | Novo Nordisk As | Prozessierung von peptiden und proteinen |
ES2397241T3 (es) | 2004-01-21 | 2013-03-05 | Novo Nordisk Health Care Ag | Conjugación de péptidos mediante transglutaminasa |
US7381794B2 (en) | 2004-03-08 | 2008-06-03 | Zymogenetics, Inc. | Dimeric fusion proteins and materials and methods for producing them |
US7537761B2 (en) | 2004-10-22 | 2009-05-26 | Zymogenetics, Inc. | Anti-IL-22RA antibodies and binding partners and methods of using in inflammation |
EP1856156A2 (en) | 2005-02-08 | 2007-11-21 | ZymoGenetics, Inc. | Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
EP2285982B1 (en) * | 2008-05-27 | 2018-04-11 | Dako Denmark A/S | Compositions and methods for detection of chromosomal aberrations with novel hybridization buffers |
EP2297203A1 (en) | 2008-06-30 | 2011-03-23 | Novo Nordisk A/S | Anti-human interleukin-20 antibodies |
WO2010042634A1 (en) * | 2008-10-07 | 2010-04-15 | National Cheng Kung University | Use of il-20 antagonists for treating rheumatoid arthritis and osteoporosis |
WO2010097656A1 (en) | 2009-02-26 | 2010-09-02 | Dako Denmark A/S | Compositions and methods for performing a stringent wash step in hybridization applications |
US8454956B2 (en) | 2009-08-31 | 2013-06-04 | National Cheng Kung University | Methods for treating rheumatoid arthritis and osteoporosis with anti-IL-20 antibodies |
EP2761028A1 (en) | 2011-09-30 | 2014-08-06 | Dako Denmark A/S | Hybridization compositions and methods using formamide |
EP3252173A1 (en) | 2011-10-21 | 2017-12-06 | Dako Denmark A/S | Hybridization compositions and methods |
AU2013228226B2 (en) * | 2012-03-05 | 2016-06-02 | Seegene, Inc. | Detection of nucleotide variation on target nucleic acid sequence by PTO cleavage and extension assay |
WO2013164440A1 (en) | 2012-05-03 | 2013-11-07 | Novo Nordisk A/S | Methods related to treatment of inflammatory diseases and disorders |
US9221904B2 (en) | 2012-07-19 | 2015-12-29 | National Cheng Kung University | Treatment of osteoarthritis using IL-20 antagonists |
US8852588B2 (en) | 2012-08-07 | 2014-10-07 | National Cheng Kung University | Treating allergic airway disorders using anti-IL-20 receptor antibodies |
US8603470B1 (en) | 2012-08-07 | 2013-12-10 | National Cheng Kung University | Use of IL-20 antagonists for treating liver diseases |
WO2017202813A1 (en) | 2016-05-24 | 2017-11-30 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment of pulmonary bacterial infections |
CN113248567B (zh) * | 2021-02-10 | 2023-02-03 | 渤海大学 | 一种苦味受体阻滞肽及其应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7155296A (en) * | 1996-08-30 | 1998-03-19 | Human Genome Sciences, Inc. | Interleukin-19 |
DK1616575T3 (da) * | 1999-12-23 | 2012-09-10 | Zymogenetics Inc | Fremgangsmåde til behandling af inflammation |
-
1998
- 1998-11-25 KR KR1020007005732A patent/KR100574387B1/ko not_active IP Right Cessation
- 1998-11-25 AT AT98960493T patent/ATE269902T1/de active
- 1998-11-25 CN CNB988124289A patent/CN1247780C/zh not_active Expired - Lifetime
- 1998-11-25 IL IL13607698A patent/IL136076A0/xx active IP Right Grant
- 1998-11-25 UA UAA200500986A patent/UA86350C2/ru unknown
- 1998-11-25 EP EP98960493A patent/EP1032671B1/en not_active Expired - Lifetime
- 1998-11-25 CA CA2312000A patent/CA2312000C/en not_active Expired - Fee Related
- 1998-11-25 ES ES98960493T patent/ES2218872T3/es not_active Expired - Lifetime
- 1998-11-25 CZ CZ20001910A patent/CZ300849B6/cs not_active IP Right Cessation
- 1998-11-25 EP EP04002769A patent/EP1424393A3/en not_active Withdrawn
- 1998-11-25 NZ NZ504751A patent/NZ504751A/en not_active IP Right Cessation
- 1998-11-25 PL PL98340755A patent/PL195304B1/pl unknown
- 1998-11-25 WO PCT/US1998/025228 patent/WO1999027103A1/en active IP Right Grant
- 1998-11-25 JP JP2000522245A patent/JP5191619B2/ja not_active Expired - Lifetime
- 1998-11-25 DE DE69824755T patent/DE69824755T2/de not_active Expired - Lifetime
- 1998-11-25 PL PL378071A patent/PL198687B1/pl unknown
- 1998-11-25 EA EA200401501A patent/EA010741B1/ru not_active IP Right Cessation
- 1998-11-25 EA EA200000565A patent/EA005581B1/ru not_active IP Right Cessation
- 1998-11-25 DK DK98960493T patent/DK1032671T3/da active
- 1998-11-25 CN CNA2004100877931A patent/CN1618969A/zh active Pending
- 1998-11-25 UA UA2000063693A patent/UA73275C2/uk unknown
- 1998-11-25 AU AU16077/99A patent/AU739420B2/en not_active Ceased
- 1998-11-25 EP EP06006241A patent/EP1719780A3/en not_active Withdrawn
- 1998-11-25 HU HU0100436A patent/HU227703B1/hu not_active IP Right Cessation
- 1998-11-25 BR BR9814904-0A patent/BR9814904A/pt not_active IP Right Cessation
-
2000
- 2000-05-09 IL IL136076A patent/IL136076A/en not_active IP Right Cessation
- 2000-05-26 NO NO20002698A patent/NO326561B1/no not_active IP Right Cessation
-
2007
- 2007-09-06 NO NO20074516A patent/NO329731B1/no not_active IP Right Cessation
-
2010
- 2010-04-30 JP JP2010105084A patent/JP5331054B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9814904A (pt) | Polinucleotìdeo isolado que codifica um polipeptìdeo, polipeptìdeo isolado, e, anticorpo. | |
PT94565A (pt) | Novos anticorpos reactivos com carcinomas humanos | |
DE68914929D1 (de) | Emulgierte Zusammensetzung. | |
DE68909037T2 (de) | Belüftung von Flüssigkeiten. | |
DE69515938D1 (de) | Reibbelagmaterialien | |
BR9307766A (pt) | Cimento moído com fibra | |
DK412489D0 (da) | Alfa-underenheden af mac-1-leukocytadhaesionsreceptoren | |
DE68909432D1 (de) | Direkte fixierung von geflochtenen strukturen. | |
DE3668200D1 (de) | Pumpbares aufschuettungsmaterial mit hoher festigkeit. | |
BR9006389A (pt) | Cimento asfaltico modificado | |
DE68910665D1 (de) | Futterstoff. | |
BR8905709A (pt) | Composicoes de cimento tixotropicas | |
DK620589A (da) | Polyester egnet til anvendelse som bindefiber eller -filament | |
DE68901414D1 (de) | Kohlenwasserstoff-dehydrierungsreakionen. | |
DE68910348D1 (de) | Dialkylaminoalkyl-hydroxyalkyläther von Galactomannanen. | |
DE69104829D1 (de) | Herstellung von reibbelägen. | |
DE68919463T2 (de) | Bremsbackenführungselement und dieses verwendende Bremse. | |
DE3750606D1 (de) | Gipsentschwefelung. | |
BR8900543A (pt) | Composicao para o beneficiamento de fibras sinteticas,processo para sua preparacao e aplicacao | |
BR8701478A (pt) | Mistura de aclaradores oticos,aplicacao e agente para o aclaramento otico de fibras | |
BR9007071A (pt) | Anticorpos de anti-idiotipos que reagem com idiotopos divididos,expressos por linfomas humanos e auto-anticorpo | |
NO902162D0 (no) | Fremstilling av bituminoes betong omfattende traadstykker. | |
DE3869884D1 (de) | Polysiloxanmodifizierter zement. | |
DE3687542T2 (de) | Monoklonaler antikoerper gegen humanes protein c. | |
DK424789A (da) | Instant mousseblanding |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: DE ACORDO COM O ART. 37, INDEFIRO DO PRESENTE PEDIDO, UMA VEZ QUE NAO APRESENTA SUFICIENCIA DESCRITIVA (ART. 24 DA LPI); AS REIVINDICACOES ESTAO INDEFINIDAS E/OU NAO ESTAO FUNDAMENTADAS NO RELATORIO DESCRITIVO (ART. 25 DA LPI). |
|
B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
B08L | Patent application lapsed because of non payment of annual fee [chapter 8.12 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DAS 13A, 14A E 15A ANUIDADES. |
|
B08I | Publication cancelled [chapter 8.9 patent gazette] |
Free format text: ANULADA A PUBLICACAO CODIGO 8.12 NA RPI NO 2256 DE 01/04/2014 POR TER SIDO INDEVIDA. |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 13A ATE A 22A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2602 DE 17-11-2020 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |